Get the Stockscreener App
1.94
0.51%
-0.01
Entera Bio Ltd stock is traded at $1.94, with a volume of 35,154.
It is down -0.51% in the last 24 hours and down -0.51% over the past month.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
See More
Previous Close:
$1.95
Open:
$2.015
24h Volume:
35,154
Relative Volume:
0.30
Market Cap:
$88.59M
Revenue:
$134.00K
Net Income/Loss:
$-9.93M
P/E Ratio:
-5.7059
EPS:
-0.34
Net Cash Flow:
$-6.72M
1W Performance:
-3.00%
1M Performance:
-0.51%
6M Performance:
-7.62%
1Y Performance:
+13.45%
1-Day Range:
$1.91
$2.015
1-Week Range:
$1.80
$2.03
52-Week Range:
$1.5006
$2.79
Entera Bio Ltd Stock (ENTX) Company Profile
Name
Entera Bio Ltd
Sector
Industry
Phone
972-2-532-7151
Address
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Compare ENTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.94 | 91.33M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-21 | Initiated | Aegis Capital | Buy |
Entera Bio Ltd Stock (ENTX) Latest News
Using AI based signals to follow Entera Bio Ltd.July 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025 - MSN
Entera Bio Ltd. Added to High Probability Setup List2025 AllTime Highs & Daily Volume Surge Signals - Newser
Earnings visualization tools for Entera Bio Ltd.Trade Signal Summary & Free Fast Gain Swing Trade Alerts - Newser
What’s next for Entera Bio Ltd. stock price2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
Is a relief rally coming for Entera Bio Ltd. holders2025 Market Outlook & Weekly Top Gainers Alerts - Newser
Real time breakdown of Entera Bio Ltd. stock performanceInsider Buying & Real-Time Market Trend Scan - Newser
Trend analysis for Entera Bio Ltd. this week2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Intraday pattern recognizer results for Entera Bio Ltd.Weekly Trade Summary & Weekly High Return Forecasts - Newser
How to recover losses in Entera Bio Ltd. stock2025 Price Action Summary & Risk Controlled Daily Trade Plans - Newser
How Entera Bio Ltd. stock performs during market volatilityJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - Newser
Entera Bio Ltd. Tests 50 Day MA After Sharp DeclineJuly 2025 WrapUp & Technical Entry and Exit Tips - classian.co.kr
Statistical indicators supporting Entera Bio Ltd.’s strengthQuarterly Portfolio Report & Trade Opportunity Analysis - Newser
How to forecast Entera Bio Ltd. trends using time seriesJuly 2025 Fed Impact & Accurate Buy Signal Notifications - Newser
What makes Entera Bio Ltd. stock price move sharplyPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
Will Entera Bio Ltd. rebound enough to break evenJuly 2025 Rallies & Comprehensive Market Scan Reports - Newser
What candlestick patterns are forming on Entera Bio Ltd.July 2025 Earnings & Consistent Growth Equity Picks - Newser
Automated trading signals detected on Entera Bio Ltd.Market Activity Summary & Daily Technical Stock Forecast Reports - Newser
Is Entera Bio Ltd. meeting your algorithmic filter criteriaInflation Watch & Verified Technical Signals - Newser
Published on: 2025-08-17 17:42:41 - Newser
Using Bollinger Bands to evaluate Entera Bio Ltd.Global Markets & Stock Timing and Entry Methods - Newser
Entera Bio Ltd. stock momentum explainedMarket Performance Summary & Fast Entry Momentum Alerts - Newser
Why Entera Bio Ltd. stock attracts strong analyst attention2025 Momentum Check & Community Supported Trade Ideas - Newser
Multi factor analysis applied to Entera Bio Ltd.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
Sentiment analysis tools applied to Entera Bio Ltd.Weekly Trade Analysis & Technical Buy Zone Confirmations - Newser
When is the best time to buy Entera Bio Ltd. stock2025 Retail Activity & Low Drawdown Trading Techniques - Newser
What the charts say about Entera Bio Ltd. today2025 Trading Recap & Intraday High Probability Setup Alerts - Newser
Is Entera Bio Ltd. stock reversal real or fake2025 Volume Leaders & High Conviction Investment Ideas - Newser
What MACD signals say about Entera Bio Ltd.Earnings Risk Report & Weekly Top Stock Performers List - Newser
How moving averages guide Entera Bio Ltd. tradingFed Meeting & Growth Focused Stock Pick Reports - Newser
Is Entera Bio Ltd. showing signs of accumulation2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Does Entera Bio Ltd. stock benefit from AI growthJuly 2025 Final Week & Safe Entry Momentum Stock Tips - newsyoung.net
Entera Bio Ltd Stock (ENTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):